Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : XENE    exchanges : Nasdaq    save search

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.73% C: 0.44%

xen1101 neurology pharmaceuticals meeting
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: -1.05% H: 1.69% C: -0.35%

conference pharmaceuticals
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 1.57% C: 0.5%

conference pharmaceuticals
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Published: 2024-03-12 (Crawled : 20:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 1.7% C: 1.53%

pharmaceuticals
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-05 (Crawled : 21:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.13% C: -0.09%

conference biopharma pharmaceuticals global
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 21:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 5.3% H: 2.6% C: -5.75%

year update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.61% C: 0.51%

conference year update pharmaceuticals financial results
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 6.05% C: 5.79%

pharmaceuticals key milestone
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 14:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 0.47% C: -1.14%

conference pharmaceuticals
Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 2.35% C: 2.19%

offering pharmaceuticals
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)
Published: 2023-12-02 (Crawled : 20:20) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
FNCTF | News | $11.0354 -20.84% 320 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

pipeline pharmaceuticals meeting
Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering
Published: 2023-11-30 (Crawled : 05:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 5.04% H: 7.59% C: 3.19%

offering pharmaceuticals
Xenon Forging Ahead in MDD Despite Mid-stage Flop
Published: 2023-11-27 (Crawled : 21:00) - biospace.com/
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.1% H: 18.14% C: 17.66%


Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD)
Published: 2023-11-27 (Crawled : 12:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.1% H: 18.14% C: 17.66%

xen1101 pharmaceuticals topline trial results
Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: -1.17% H: 2.36% C: -2.77%
NBIX M | $132.03 -0.39% -0.39% 560K twitter stocktwits trandingview |
Health Technology
| | O: -5.22% H: 1.98% C: 0.82%

update pharmaceuticals program
Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 3.95% H: 2.47% C: -10.23%

update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-11-01 (Crawled : 20:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 1.06% H: 4.96% C: 4.82%

conference update pharmaceuticals financial results
Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology
Published: 2023-10-09 (Crawled : 20:00) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.31% H: 3.31% C: 3.06%

xen1101 publication pharmaceuticals trial results
New Investigational Drug Offers Relief for Treatment-Resistant Epilepsy Patients
Published: 2023-10-09 (Crawled : 15:00) - prnewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: -0.62% H: 1.44% C: 0.28%

drug
Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit
Published: 2023-10-06 (Crawled : 12:30) - globenewswire.com
XENE | $39.91 -0.99% -1.0% 360K twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 1.96% C: 1.19%

biotech pharmaceuticals
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.